Tentang kami

Selamat datang di Zeta Pharma

Zeta Pharma adalah perusahaan Mesir yang berkembang pesat, didirikan pada tahun 2010 untuk menjadi nilai tambah bagi industri farmasi.

Zeta Pharma memiliki portofolio produk yang baik dan unik di semua bidang terapi.

Perusahaan Zeta Pharma memulai kegiatan pemasarannya pada tahun 2015 dengan produk pengobatan Hepatitis C (Sofocivir, Zetaciver & Sofocivir Plus).

Bekerja sama dengan Kementerian Kesehatan Mesir dan Lembaga Penelitian Hati di Mesir, ZETA PHARMA® telah berhasil merawat lebih dari 60.000 pasien dengan tingkat kesembuhan 95% serupa dengan tingkat global

Misi dan Visi Kami

Visi Kami

Kami bekerja keras untuk menjadi salah satu mitra farmasi yang paling dipercaya masyarakat yang peduli dengan kualitas hidup masyarakat di kawasan Timur Tengah – Afrika

Misi

We are committed to provide our communities across the Middle East-Africa region with affordable, high-quality pharmaceutical integrated solutions. Our state of art production facility designed to comply with GMP and WHO standards. ZETA PHARMA® also invests in human capital through attracting, cultivating and retaining excellent talents with passionate commitment to ZETA PHARMA’S work ethic and strong core values. Integrating the most cutting-edge science with the best human caliber in the market allows us to serve as a reliable partner in the healthcare system.

Zeta Pharma Factory

ZETA Pharma maintains one of the broadest quality-products portfolio within the industry and as an optimistic view to the future, the board decided to establish a manufacturing facility comply with the cGMP Standards in 7500 m2 area.

Sejarah Zeta

Cool Timeline

2022
September

2022 launched New 9 Products

2022 launched New 9 Products

1-Nexirozova Launch:

Jan – 2022, Zeta Pharma launched Nexirozova; a new generic of the anti-dyslipidemic molecule Rosuvastatin 5,10,20mg,

Click Here To See More.

2021
Desember

2021 Launched New 7 Products

2021 Launched New 7 Products

1- Bilastegic Launch:

Jan – 2021, Zeta Pharma launched its new product, Bilastegic the world’s latest and most effective product for allergic diseases,

Click Here To See More.

2020
Juli

EBRD Agreement 2020

EBRD Agreement 2020

The European Bank for Reconstruction and Development (EBRD) is providing consultancy studies to Zeta Pharma factory in Egypt to qualify for European GMP accreditation.

Click Here To See More.

April

2020 Launched New 4 Products

2020 Launched New 4 Products

1- Empacoza Lunch:

Zeta Pharma launches “Empacoza” type 2 diabetes medicine in the Egyptian Market, In presence of famous Egyptian professors of Internal medication and endocrinology,

Click Here To See More.

2019
Mei

2019 Launched New 5 Products

2019 Launched New 5 Products

1- Ancavaz Launch:

Zeta launched Ancavaz -which is indicated as a substitution therapy for the treatment of hypertension and/or stable coronary heart disease,

Click Here To See More.

2018
Oktober

2018 Launched 4 New Products

2018 Launched 4 New Products

1- Nexicure Launch:

12/10/2018

Zeta launched Nexicure Esomeprazole 20/40 mg MUPS tablet,

Click Here To See More.

2017
Desember

100 Millions Seha

100 Millions Seha

Interview with Major General Mahmoud Ashmawi, Governor of Qalyubia governorate, and Dr. Hamdi El Tabakh, the Ministry of Health representative in Qalyubia in the launch of the Hepatitis C eradication campaign,

Click Here To See More.

2015
Desember

HCV Launch

HCV Launch

Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).

Click Here To See More.